Daniel Paul Dickstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 70 | 2023 | 5138 | 5.380 |
Why?
|
Irritable Mood | 11 | 2024 | 196 | 2.490 |
Why?
|
Self-Injurious Behavior | 8 | 2022 | 570 | 2.380 |
Why?
|
Suicide, Attempted | 11 | 2023 | 1409 | 1.940 |
Why?
|
Reversal Learning | 7 | 2016 | 55 | 1.870 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 24 | 2024 | 3719 | 1.800 |
Why?
|
Suicidal Ideation | 10 | 2022 | 1461 | 1.650 |
Why?
|
Facial Expression | 8 | 2015 | 516 | 1.440 |
Why?
|
Adolescent Behavior | 7 | 2022 | 1185 | 1.420 |
Why?
|
Emotions | 11 | 2022 | 2763 | 1.130 |
Why?
|
Mood Disorders | 11 | 2024 | 1128 | 1.110 |
Why?
|
Adolescent | 94 | 2024 | 88835 | 1.010 |
Why?
|
Anxiety Disorders | 14 | 2024 | 2737 | 0.970 |
Why?
|
Executive Function | 9 | 2021 | 1391 | 0.900 |
Why?
|
Child Psychiatry | 3 | 2024 | 233 | 0.890 |
Why?
|
Affective Symptoms | 3 | 2020 | 417 | 0.880 |
Why?
|
Emotional Intelligence | 2 | 2015 | 135 | 0.880 |
Why?
|
Family Relations | 3 | 2018 | 318 | 0.880 |
Why?
|
Child | 75 | 2023 | 80564 | 0.820 |
Why?
|
Rest | 3 | 2019 | 942 | 0.790 |
Why?
|
Guilt | 1 | 2022 | 93 | 0.750 |
Why?
|
Cognition | 9 | 2022 | 7049 | 0.700 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 7 | 2024 | 307 | 0.670 |
Why?
|
Caudate Nucleus | 4 | 2018 | 387 | 0.660 |
Why?
|
Brain Mapping | 11 | 2019 | 6601 | 0.650 |
Why?
|
Frontal Lobe | 7 | 2018 | 1410 | 0.650 |
Why?
|
Brain | 16 | 2022 | 27171 | 0.620 |
Why?
|
Risk-Taking | 2 | 2023 | 1021 | 0.600 |
Why?
|
Face | 3 | 2015 | 1028 | 0.600 |
Why?
|
Magnetic Resonance Imaging | 23 | 2023 | 36532 | 0.580 |
Why?
|
Temporal Lobe | 3 | 2012 | 1714 | 0.570 |
Why?
|
Cues | 1 | 2022 | 877 | 0.560 |
Why?
|
Child Abuse | 2 | 2022 | 1090 | 0.530 |
Why?
|
Depressive Disorder, Major | 6 | 2023 | 4808 | 0.510 |
Why?
|
Neuropsychological Tests | 17 | 2021 | 7123 | 0.490 |
Why?
|
Amygdala | 6 | 2014 | 1377 | 0.470 |
Why?
|
Age Factors | 12 | 2018 | 18380 | 0.470 |
Why?
|
Attention | 9 | 2020 | 2419 | 0.470 |
Why?
|
Maternal Age | 1 | 2017 | 804 | 0.450 |
Why?
|
Risperidone | 2 | 2016 | 383 | 0.440 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2020 | 1484 | 0.430 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 346 | 0.430 |
Why?
|
Diseases in Twins | 1 | 2015 | 448 | 0.420 |
Why?
|
Cognition Disorders | 5 | 2015 | 3967 | 0.420 |
Why?
|
Affect | 6 | 2020 | 1500 | 0.410 |
Why?
|
Humans | 115 | 2024 | 765968 | 0.400 |
Why?
|
Sleep Deprivation | 1 | 2019 | 845 | 0.390 |
Why?
|
Psychomotor Performance | 6 | 2015 | 1881 | 0.390 |
Why?
|
Child Development Disorders, Pervasive | 3 | 2013 | 597 | 0.390 |
Why?
|
Attitude to Death | 1 | 2015 | 399 | 0.380 |
Why?
|
Panic Disorder | 2 | 2014 | 610 | 0.380 |
Why?
|
Male | 82 | 2023 | 363698 | 0.370 |
Why?
|
Female | 80 | 2023 | 396112 | 0.370 |
Why?
|
Nerve Net | 2 | 2014 | 2309 | 0.370 |
Why?
|
Antipsychotic Agents | 3 | 2016 | 3076 | 0.360 |
Why?
|
Interpersonal Relations | 2 | 2015 | 1432 | 0.360 |
Why?
|
Comorbidity | 16 | 2019 | 10563 | 0.340 |
Why?
|
Social Problems | 1 | 2010 | 107 | 0.340 |
Why?
|
Personality Development | 1 | 2010 | 242 | 0.340 |
Why?
|
Age of Onset | 8 | 2023 | 3344 | 0.330 |
Why?
|
Behavior Therapy | 1 | 2015 | 884 | 0.330 |
Why?
|
Prefrontal Cortex | 9 | 2016 | 2224 | 0.320 |
Why?
|
Corpus Striatum | 3 | 2012 | 1218 | 0.320 |
Why?
|
Valproic Acid | 1 | 2012 | 445 | 0.320 |
Why?
|
Antimanic Agents | 3 | 2011 | 523 | 0.310 |
Why?
|
Social Control, Informal | 1 | 2009 | 44 | 0.310 |
Why?
|
Metformin | 1 | 2016 | 904 | 0.310 |
Why?
|
Mental Disorders | 7 | 2023 | 6853 | 0.300 |
Why?
|
Lithium Carbonate | 1 | 2009 | 179 | 0.300 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 902 | 0.290 |
Why?
|
Young Adult | 19 | 2023 | 59889 | 0.280 |
Why?
|
Adolescent Psychiatry | 1 | 2009 | 166 | 0.280 |
Why?
|
Parents | 2 | 2020 | 3592 | 0.280 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2798 | 0.250 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 26318 | 0.250 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 820 | 0.250 |
Why?
|
Social Perception | 5 | 2015 | 436 | 0.250 |
Why?
|
Periodicity | 1 | 2007 | 345 | 0.250 |
Why?
|
Visual Perception | 5 | 2015 | 1394 | 0.250 |
Why?
|
Cerebral Cortex | 2 | 2014 | 5767 | 0.250 |
Why?
|
Social Adjustment | 2 | 2018 | 633 | 0.250 |
Why?
|
Arousal | 2 | 2008 | 1171 | 0.240 |
Why?
|
Case-Control Studies | 11 | 2020 | 22223 | 0.230 |
Why?
|
Neural Pathways | 3 | 2010 | 3085 | 0.230 |
Why?
|
Memory | 3 | 2018 | 2190 | 0.230 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2020 | 6014 | 0.220 |
Why?
|
Gyrus Cinguli | 4 | 2023 | 1117 | 0.210 |
Why?
|
Functional Laterality | 7 | 2010 | 2243 | 0.200 |
Why?
|
Neurologic Examination | 1 | 2005 | 912 | 0.200 |
Why?
|
Adolescent Development | 2 | 2016 | 275 | 0.200 |
Why?
|
Editorial Policies | 2 | 2024 | 458 | 0.200 |
Why?
|
Aging | 2 | 2018 | 8731 | 0.200 |
Why?
|
Adult | 25 | 2023 | 223044 | 0.190 |
Why?
|
Anticonvulsants | 1 | 2012 | 1921 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2009 | 3672 | 0.190 |
Why?
|
Writing | 1 | 2023 | 199 | 0.190 |
Why?
|
Space Perception | 2 | 2005 | 469 | 0.190 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2021 | 75 | 0.180 |
Why?
|
Longitudinal Studies | 10 | 2020 | 14751 | 0.170 |
Why?
|
Impulsive Behavior | 1 | 2022 | 344 | 0.160 |
Why?
|
Stress, Psychological | 1 | 2015 | 4533 | 0.160 |
Why?
|
Cost of Illness | 1 | 2009 | 1950 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3356 | 0.160 |
Why?
|
Child Development | 3 | 2016 | 2327 | 0.160 |
Why?
|
Self Report | 3 | 2023 | 3770 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 2 | 2020 | 2410 | 0.150 |
Why?
|
Mother-Child Relations | 1 | 2022 | 499 | 0.150 |
Why?
|
Phenotype | 5 | 2014 | 16721 | 0.150 |
Why?
|
Diagnosis, Differential | 7 | 2018 | 12976 | 0.150 |
Why?
|
Social Environment | 2 | 2017 | 1011 | 0.150 |
Why?
|
Trichotillomania | 1 | 2020 | 178 | 0.150 |
Why?
|
Inositol | 2 | 2009 | 215 | 0.140 |
Why?
|
Peer Group | 1 | 2023 | 701 | 0.140 |
Why?
|
Antigens, Dermatophagoides | 1 | 2017 | 101 | 0.140 |
Why?
|
Child Behavior | 3 | 2020 | 865 | 0.140 |
Why?
|
Depression | 6 | 2023 | 8237 | 0.140 |
Why?
|
Pyroglyphidae | 1 | 2017 | 94 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2012 | 8923 | 0.140 |
Why?
|
Lipid Peroxides | 1 | 2016 | 73 | 0.140 |
Why?
|
Personality | 1 | 2020 | 560 | 0.130 |
Why?
|
Parenting | 1 | 2022 | 709 | 0.130 |
Why?
|
Prospective Studies | 7 | 2023 | 54802 | 0.130 |
Why?
|
Creatine | 2 | 2009 | 424 | 0.130 |
Why?
|
Substance-Related Disorders | 3 | 2020 | 4416 | 0.130 |
Why?
|
Aspartic Acid | 2 | 2009 | 576 | 0.130 |
Why?
|
Lipid Peroxidation | 1 | 2016 | 275 | 0.130 |
Why?
|
Reference Values | 4 | 2015 | 4908 | 0.130 |
Why?
|
Aldehydes | 1 | 2016 | 168 | 0.130 |
Why?
|
Principal Component Analysis | 1 | 2018 | 951 | 0.120 |
Why?
|
Problem Solving | 1 | 2018 | 440 | 0.120 |
Why?
|
Nucleus Accumbens | 2 | 2010 | 360 | 0.120 |
Why?
|
Postpartum Period | 1 | 2022 | 1205 | 0.120 |
Why?
|
Glutamine | 2 | 2009 | 576 | 0.120 |
Why?
|
Probability | 2 | 2010 | 2475 | 0.120 |
Why?
|
Anisotropy | 1 | 2018 | 1282 | 0.110 |
Why?
|
Disease Progression | 3 | 2020 | 13632 | 0.110 |
Why?
|
Outpatients | 1 | 2022 | 1595 | 0.110 |
Why?
|
Risk Factors | 11 | 2022 | 74840 | 0.110 |
Why?
|
Uncertainty | 1 | 2018 | 761 | 0.110 |
Why?
|
Skin | 2 | 2017 | 4489 | 0.110 |
Why?
|
Severity of Illness Index | 9 | 2013 | 15880 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1462 | 0.110 |
Why?
|
Euphoria | 1 | 2013 | 64 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 605 | 0.100 |
Why?
|
Suicide | 2 | 2019 | 1604 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1303 | 0.100 |
Why?
|
Triglycerides | 2 | 2019 | 2441 | 0.100 |
Why?
|
Basal Ganglia | 3 | 2009 | 549 | 0.100 |
Why?
|
Mothers | 1 | 2022 | 2210 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2936 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1808 | 0.090 |
Why?
|
Family | 2 | 2020 | 3209 | 0.090 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2020 | 1989 | 0.090 |
Why?
|
Photic Stimulation | 2 | 2015 | 1993 | 0.090 |
Why?
|
Psychiatry | 1 | 2023 | 1714 | 0.090 |
Why?
|
Behavior Control | 1 | 2010 | 46 | 0.090 |
Why?
|
Human Development | 1 | 2010 | 122 | 0.080 |
Why?
|
Memory, Short-Term | 1 | 2016 | 1003 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1811 | 0.080 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 729 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3850 | 0.070 |
Why?
|
Psychometrics | 2 | 2015 | 3062 | 0.070 |
Why?
|
Psychotropic Drugs | 2 | 2005 | 879 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2010 | 6203 | 0.070 |
Why?
|
Phosphocreatine | 1 | 2008 | 258 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2975 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5501 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2008 | 616 | 0.070 |
Why?
|
Lithium Compounds | 1 | 2008 | 226 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2018 | 3212 | 0.060 |
Why?
|
Happiness | 1 | 2007 | 173 | 0.060 |
Why?
|
Weight Gain | 1 | 2016 | 2355 | 0.060 |
Why?
|
Perceptual Disorders | 1 | 2008 | 199 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3222 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 1988 | 381 | 0.060 |
Why?
|
Anger | 1 | 2007 | 402 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2009 | 1589 | 0.060 |
Why?
|
Evoked Potentials | 2 | 2007 | 1048 | 0.060 |
Why?
|
Conduct Disorder | 1 | 2006 | 246 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4348 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2009 | 12437 | 0.060 |
Why?
|
Waist Circumference | 2 | 2019 | 932 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2007 | 462 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3110 | 0.050 |
Why?
|
Hypertension, Renovascular | 1 | 2003 | 113 | 0.050 |
Why?
|
Nonverbal Communication | 3 | 2008 | 63 | 0.050 |
Why?
|
Oxygen | 2 | 2010 | 4241 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 323 | 0.050 |
Why?
|
Infant | 2 | 2022 | 36386 | 0.050 |
Why?
|
Prevalence | 4 | 2019 | 15842 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5876 | 0.040 |
Why?
|
Atrophy | 1 | 2005 | 1635 | 0.040 |
Why?
|
United States | 5 | 2019 | 72903 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2009 | 1239 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2021 | 525 | 0.040 |
Why?
|
Sex Factors | 2 | 2020 | 10603 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15398 | 0.040 |
Why?
|
Anxiety | 2 | 2024 | 4671 | 0.040 |
Why?
|
Social Support | 1 | 1988 | 2192 | 0.040 |
Why?
|
Memory Disorders | 1 | 2005 | 1194 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 730 | 0.040 |
Why?
|
Demography | 2 | 2017 | 1641 | 0.040 |
Why?
|
Reaction Time | 3 | 2010 | 2086 | 0.040 |
Why?
|
Clobetasol | 1 | 2017 | 33 | 0.030 |
Why?
|
Chronic Disease | 2 | 2011 | 9347 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 13076 | 0.030 |
Why?
|
Betamethasone | 1 | 2017 | 48 | 0.030 |
Why?
|
Asperger Syndrome | 1 | 2016 | 57 | 0.030 |
Why?
|
Reward | 2 | 2018 | 981 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 21480 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10850 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2686 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 647 | 0.030 |
Why?
|
Behavioral Symptoms | 1 | 2017 | 187 | 0.030 |
Why?
|
Chorea | 1 | 1995 | 80 | 0.030 |
Why?
|
Developmental Disabilities | 2 | 2005 | 1519 | 0.030 |
Why?
|
Administration, Topical | 1 | 2017 | 704 | 0.030 |
Why?
|
Death | 1 | 2019 | 686 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39193 | 0.030 |
Why?
|
Hyperplasia | 1 | 2017 | 1144 | 0.030 |
Why?
|
Food | 1 | 2018 | 764 | 0.030 |
Why?
|
Tacrolimus | 1 | 2017 | 753 | 0.030 |
Why?
|
Placebo Effect | 1 | 2017 | 514 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1811 | 0.030 |
Why?
|
Eosinophils | 1 | 2017 | 945 | 0.030 |
Why?
|
Hippocampus | 1 | 2005 | 3775 | 0.030 |
Why?
|
Employment | 1 | 2018 | 1106 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7421 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 975 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 674 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2012 | 255 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 128 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2018 | 1820 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1138 | 0.020 |
Why?
|
Task Performance and Analysis | 2 | 2005 | 770 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 81514 | 0.020 |
Why?
|
Lithium | 1 | 2013 | 597 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2966 | 0.020 |
Why?
|
Brain Diseases | 1 | 1999 | 1546 | 0.020 |
Why?
|
Hospitalization | 2 | 2005 | 10808 | 0.020 |
Why?
|
Child, Preschool | 4 | 2008 | 42500 | 0.020 |
Why?
|
Psoriasis | 1 | 2017 | 919 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9591 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1884 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3278 | 0.020 |
Why?
|
Washington | 1 | 1988 | 314 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 106 | 0.020 |
Why?
|
Eleutherococcus | 1 | 2007 | 5 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2008 | 284 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2008 | 328 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3271 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2747 | 0.020 |
Why?
|
Cost Control | 1 | 1988 | 624 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2411 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 1253 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2564 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3141 | 0.020 |
Why?
|
Drugs, Chinese Herbal | 1 | 2007 | 142 | 0.020 |
Why?
|
Antidepressive Agents | 2 | 2011 | 2897 | 0.020 |
Why?
|
Language Tests | 1 | 2005 | 191 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8733 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3529 | 0.010 |
Why?
|
Testicular Hydrocele | 1 | 2003 | 27 | 0.010 |
Why?
|
Personality Assessment | 1 | 2005 | 646 | 0.010 |
Why?
|
Judgment | 1 | 2005 | 270 | 0.010 |
Why?
|
Psychosomatic Medicine | 1 | 2003 | 72 | 0.010 |
Why?
|
Aggression | 1 | 2007 | 748 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9525 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2005 | 1255 | 0.010 |
Why?
|
Animals | 3 | 2024 | 168764 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8501 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10261 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3432 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11641 | 0.010 |
Why?
|
Visual Cortex | 1 | 2007 | 1085 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 30260 | 0.010 |
Why?
|
Aged | 3 | 2019 | 171117 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4255 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24282 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 223009 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 1999 | 499 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1999 | 1006 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 1996 | 222 | 0.010 |
Why?
|
Intelligence Tests | 1 | 1996 | 504 | 0.010 |
Why?
|
Globus Pallidus | 1 | 1996 | 248 | 0.010 |
Why?
|
Magnetoencephalography | 1 | 1999 | 585 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2778 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1145 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1996 | 549 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12056 | 0.010 |
Why?
|
Body Height | 1 | 1996 | 1562 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41649 | 0.010 |
Why?
|
Schizophrenia | 1 | 1988 | 6972 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2699 | 0.000 |
Why?
|
Cerebellum | 1 | 1996 | 1518 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 65188 | 0.000 |
Why?
|
Body Weight | 1 | 1996 | 4622 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1988 | 59489 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1999 | 26346 | 0.000 |
Why?
|